CPT 95981: Gastric Neurostimulator Electronic Analysis
CPT code 95981 covers a subsequent electronic analysis of an already implanted gastric neurostimulator pulse generator to confirm device function without reprogramming. This code is used nationally for follow-up device checks after implantation and is relevant to gastroenterology, pain management, and device clinics that manage neurostimulation for conditions such as gastroparesis.
Key payers in the landscape include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the service captured by the code, typical sites of service, and the clinical context in which the code is used. The publication outlines what stakeholders can expect to learn about coding application and claim categorization, payer coverage considerations, and common billing modifiers and administrative details that affect claim processing.
The content provides national-level perspective rather than state-specific policy, offering benchmarks and practical policy context for hospitals, ambulatory clinics, and physician practices that perform device interrogations. Data not available in the input for some elements such as associated taxonomies, specific ICD-10 pairings, and payer-specific reimbursement rates.
Sign up for cpt 95981 policy alerts
Get alerted when payer policies referencing 95981 are released or updated.
Billing Code Overview
CPT code 95981 describes a subsequent electronic analysis of a previously implanted gastric neurostimulator pulse generator system to verify device function. This procedure involves interrogation and assessment of the implanted pulse generator without performing device reprogramming.
-
Service type: Device interrogation / electronic analysis
-
Typical site of service: Outpatient setting, device clinic, or ambulatory surgical center where implanted neurostimulator follow-up is performed. If facility type is not specified in the input, Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 48-year-old patient with an implanted gastric neurostimulator (gastric electrical stimulation device) placed previously for refractory gastroparesis presents to the outpatient neuromodulation clinic for device surveillance. The visit includes a focused history about symptom control (nausea, vomiting, early satiety), interrogation of the implanted pulse generator using the manufacturer programmer to perform electronic analysis, review of battery status, lead impedance measurements, and confirmation that stimulation delivery parameters remain intact. The provider does not perform reprogramming during this encounter. Typical workflow: check-in and device chart review, consent for device interrogation, connect external programmer wand to the generator and run diagnostics, document results and any recommendations, and arrange follow-up or scheduling for reprogramming or surgical revision if a malfunction or battery depletion is detected.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Use when no specific modifier applies to the service |
11 | Office/Outpatient Visit | Use to indicate a standard professional encounter in clinic when reporting services requiring this modifier per payer rules |
22 | Increased Procedural Services | Use when the electronic analysis required substantially greater work than typical (rare for simple interrogation; use cautiously and with documentation) |
26 | Professional Component | Use when reporting only the physician professional interpretation component separate from technical device interrogation provided by hospital or facility |
52 | Reduced Services | Use when the interrogation was started but not completed and a reduced service was provided |
53 | Discontinued Procedure | Use if attempted interrogation was discontinued for extenuating patient-related circumstances |
78 | Return to Operating Room for Related Procedure During Postop Period | Use only if interrogation leads to an immediate return to the OR for device revision during the global period of the original implant |
80 | Assistant Surgeon | Use if an assistant surgeon provided surgical assistance when a procedure related to the device was performed concurrently (rare for pure interrogation) |
81 | Minimum Assistant Surgeon | Use for a designated minimum assistant role during a related surgical procedure |
82 | Assistant Surgeon (When Qualified Resident Not Available) | Use if a qualified resident is not available and an assistant surgeon is used during related surgery |
TC | Technical Component | Use when reporting only the technical component (device interrogation performed by hospital/facility staff) separate from the physician professional component |
QK | Medical Direction of Two, Three, or Four Anesthetists | Not typically used for interrogation; included for completeness when anesthesia services overlap |
QX | CRNA Service With Medical Direction | Not typically applicable to device interrogation but may be present when anesthesia is provided for related procedures |
QY | Medical Direction of One CRNA by Anesthesiologist | Not typically applicable to device interrogation |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
207RH0000X | Gastroenterology | Gastroenterologists commonly manage gastroparesis and follow implanted gastric stimulators |
207L00000X | General Surgery | Surgeons perform device implantation and revisions; may perform interrogation in perioperative settings |
2084P0800X | Neurology | Neurologists with neuromodulation focus may be involved in device management and interpretation |
363L00000X | Pain Medicine | Pain specialists experienced in neuromodulation techniques may follow implantable stimulators |
2084N0400X | Colorectal Surgery | Colorectal surgeons occasionally involved when surgical access or revisions are required |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
K31.84 | Gastroparesis | Primary indication for gastric neurostimulator implantation and reason for routine device interrogation |
R11.0 | Nausea | Symptom commonly monitored to assess device effectiveness during interrogation visits |
R11.2 | Persistent vomiting | Symptom targeted for improvement with gastric stimulation; persistence prompts device check |
K59.1 | Functional diarrhea | Associated GI motility disorders that may co-occur and be reviewed during device follow-up |
K52.9 | Noninfective gastroenteritis and colitis, unspecified | Differential diagnosis in patients with GI symptoms assessed alongside device function |
G90.9 | Disorder of the autonomic nervous system, unspecified | Autonomic dysfunction can contribute to gastroparesis and be relevant to device therapy |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
95982 | Electronic analysis of implanted neurostimulator pulse generator system, with reprogramming | Performed when interrogation identifies a need to change stimulation parameters; follows 95981 if reprogramming is done during the visit |
64555 | Percutaneous implantation of neurostimulator electrode array; peripheral nerve (excluding sacral nerve) or subcutaneous | Related implantation code for stimulation systems; represents the initial procedure that may precede device interrogation |
64590 | Insertion or replacement of peripheral or gastric neurostimulator pulse generator or receiver, direct or open approach | Used for generator replacement or revision when interrogation shows battery depletion or malfunction requiring surgery |
95970 | Electronic analysis of spinal neurostimulator pulse generator system (other than gastric) | Analogous analysis code for other implanted stimulators; useful for billing comparisons and guidance |
99090 | Electronic analysis of device data, requiring a qualified health care professional, e.g., programming, data review | Used in some payer policies for remote monitoring or complex data analysis related to implanted devices |